Results 61 to 70 of about 3,505 (170)

OnabotulinumtoxinA for neurogenic detrusor overactivity and dose differences: a systematic review [PDF]

open access: yesInternational braz j urol, 2015
To evaluate the efficacy and safety of onabotulinumtoxinA for patients with neurogenic detrusor overactivity (NDO).We searched the Cochrane Library, PUBMED, EMBASE, Chinese Bio-medicine database, China Journal Full-text Database, VIP database, Wanfang database for randomized controlled trials (from inception to September 2012).
Zhang, Rui   +5 more
openaire   +5 more sources

Urodynamic Voiding Patterns in Multiple Sclerosis

open access: yesNeurourology and Urodynamics, Volume 45, Issue 8, Page 1569-1577, November 2026.
ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel   +5 more
wiley   +1 more source

OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity [PDF]

open access: yesNeurology, 2013
To evaluate the effects of onabotulinumtoxinA on patient-reported outcomes including health-related quality of life (HRQOL), treatment satisfaction, and treatment goal attainment in patients with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO).In this multicenter, double-blind, randomized, placebo-controlled, phase III, 52-week ...
Michael B, Chancellor   +7 more
openaire   +2 more sources

Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers‐Danlos Syndrome

open access: yesNeurourology and Urodynamics, Volume 45, Issue 8, Page 1687-1691, November 2026.
ABSTRACT Introduction and Objectives Hypermobile Ehlers‐Danlos Syndrome (hEDS) is the most common subtype of Ehlers‐Danlos Syndrome, a group of connective tissue disorders caused by collagen abnormalities. While musculoskeletal features of hEDS are well characterized, its impact on visceral organs, including the bladder, remains underexplored.
Marium Ansari   +5 more
wiley   +1 more source

Are Age and Voided Volume Sufficient to Predict Detrusor Underactivity in Women? An External Validation Study

open access: yesNeurourology and Urodynamics, Volume 45, Issue 8, Page 1556-1561, November 2026.
ABSTRACT Purpose Detrusor underactivity (DU) is a significant cause of female lower urinary tract symptoms. We aimed to externally validate a non‐invasive prediction model using age and voided volume (VV) in a tertiary center cohort. Methods This retrospective study included 450 consecutive women who underwent uroflowmetry and subsequently multichannel
Netanel Levin   +7 more
wiley   +1 more source

Long‐Term Outcomes of Sacral Neuromodulation Explantation: A 12‐Year Experience at a High‐Volume Tertiary Center

open access: yesNeurourology and Urodynamics, Volume 45, Issue 8, Page 1671-1677, November 2026.
ABSTRACT Introduction Sacral neuromodulation (SNM) is a therapeutic option offered to patients with idiopathic overactive bladder (OAB) or non‐obstructive urinary retention, as an alternative treatment for refractory medical management. It allows for electrical stimulation of inhibitory circuits that modulate the micturition reflex and improve lower ...
Carly Fiorido   +10 more
wiley   +1 more source

Myostatin‐dependent detrusor remodelling mediates contractility impairment in diabetic rats’ bladder – a maximal elastance analysis

open access: yesThe Journal of Physiology, Volume 604, Issue 20, Page 8428-8449, 15 October 2026.
Abstract figure legend In the muscular layer of long‐standing diabetic bladders increased myostatin expression promotes tissue remodelling by reducing the muscle‐to‐collagen ratio, ultimately diminishing bladder contractility. Maximal elastance – defined as the slope of the end‐emission pressure–volume relationship (EPR), derived from the regression ...
Cheng‐Yuan Lai   +6 more
wiley   +1 more source

Fahr Syndrome Unknown Complication: Overactive Bladder

open access: yesCase Reports in Urology, 2014
A 38-year-old male patient was admitted to our outpatient department because of frequency and urgency incontinence. During evaluation it was detected that the patient was suffering from frequency which was progressive for one year, feeling of ...
Devrim Tuglu   +6 more
doaj   +1 more source

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment‐Related Associations

open access: yesMuscle &Nerve, Volume 74, Issue S1, Page S97-S107, September 2026.
ABSTRACT Urinary dysfunction has been reported in association with myasthenic syndromes, including myasthenia gravis (MG), Lambert–Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS), but evidence regarding its prevalence, clinical impact, pathophysiology, and management remains limited.
Julia M. Augustin   +13 more
wiley   +1 more source

Urodynamic evaluation of neurogenic lower urinary tract dysfunction in children with Guillain-Barre syndrome within 6 months

open access: yesFrontiers in Neurology
ObjectiveThis study aimed to evaluate urodynamic characteristics, identify high-risk and unfavorable urodynamic findings in children with neurogenic lower urinary tract dysfunction (NLUTD) secondary to Guillain-Barre syndrome (GBS) within 6 months since ...
Yan Long   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy